Frontlight ResearchEarly access
Trial site
Southwest General Healthcare Center
- 9running trials
- 6closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)5 trials
- Obesity4 trials
- Type 2 diabetes4 trials
- Liver cirrhosis2 trials
- Type 1 diabetes2 trials
- Bronchiectasis1 trial
- Cushing's syndrome1 trial
- Cystic fibrosis1 trial
- Familial hypercholesterolaemia1 trial
- Phase
- Phase 211 trials
- Phase 1/22 trials
- Phase 31 trial
- Phase 41 trial
- Status
- Completed6 trials
- Recruiting5 trials
- Active, not recruiting4 trials
- Lead sponsor
- Biomea Fusion Inc.3 trials
- Regeneron Pharmaceuticals3 trials
- Armata Pharmaceuticals, Inc.1 trial
- COUR Pharmaceutical Development Company, Inc.1 trial
- Currax Pharmaceuticals1 trial
- and 6 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)2 recruiting
- Type 2 diabetes2 recruiting
- Liver cirrhosis1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
Completed
Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026